- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Socioeconomic inequalities in mortality from conditions amenable to medical interventions: do they reflect inequalities in access or quality of health care?
- Iris Plug1,
- Rasmus Hoffmann1,
- Barbara Artnik2,
- Matthias Bopp3,
- Carme Borrell4,
- Giuseppe Costa5, 6,
- Patrick Deboosere7,
- Santi Esnaola8,
- Ramune Kalediene9,
- Mall Leinsalu10, 11,
- Olle Lundberg12,
- Pekka Martikainen13,
- Enrique Regidor14,
- Jitka Rychtarikova15,
- Björn Heine Strand16,
- Bogdan Wojtyniak17 and
- Johan P Mackenbach1, 18Email author
© Plug et al.; licensee BioMed Central Ltd. 2012
Received: 21 December 2011
Accepted: 11 May 2012
Published: 11 May 2012
Previous studies have reported large socioeconomic inequalities in mortality from conditions amenable to medical intervention, but it is unclear whether these can be attributed to inequalities in access or quality of health care, or to confounding influences such as inequalities in background risk of diseases. We therefore studied whether inequalities in mortality from conditions amenable to medical intervention vary between countries in patterns which differ from those observed for other (non-amenable) causes of death. More specifically, we hypothesized that, as compared to non-amenable causes, inequalities in mortality from amenable causes are more strongly associated with inequalities in health care use and less strongly with inequalities in common risk factors for disease such as smoking.
Cause-specific mortality data for people aged 30–74 years were obtained for 14 countries, and were analysed by calculating age-standardized mortality rates and relative risks comparing a lower with a higher educational group. Survey data on health care use and behavioural risk factors for people aged 30–74 years were obtained for 12 countries, and were analysed by calculating age-and sex-adjusted odds ratios comparing a low with a higher educational group. Patterns of association were explored by calculating correlation coefficients.
In most countries and for most amenable causes of death substantial inequalities in mortality were observed, but inequalities in mortality from amenable causes did not vary between countries in patterns that are different from those seen for inequalities in non-amenable mortality. As compared to non-amenable causes, inequalities in mortality from amenable causes are not more strongly associated with inequalities in health care use. Inequalities in mortality from amenable causes are also not less strongly associated with common risk factors such as smoking.
We did not find evidence that inequalities in mortality from amenable conditions are related to inequalities in access or quality of health care. Further research is needed to find the causes of socio-economic inequalities in mortality from amenable conditions, and caution should be exercised in interpreting these inequalities as indicating health care deficiencies.
Socioeconomic inequalities in health are one of the main challenges for public health . Systematic inequalities in morbidity and mortality between socioeconomic groups exist in all countries with available data , and have not diminished in recent decades. In countries with good time trend data there is even evidence that inequalities in mortality have widened over time [3, 4].
One factor that may contribute to health inequalities is lack of access to good quality health care in lower socioeconomic groups. The evidence on this point, however, is inconclusive, particularly for high income countries with publicly financed health care systems. In the latter, lower socioeconomic groups tend to use more care than higher socioeconomic groups in accordance with their higher levels of need [5, 6], and although health care outcomes are sometimes less good for patients with a lower socioeconomic status, it is difficult to find direct evidence on the contribution of health care factors to e.g. inequalities in mortality at the population level.
It is for this reason that some studies have looked at inequalities in mortality from conditions considered to be amenable to medical intervention. This approach originates from the Working Group on Preventable and Manageable Diseases led by David Rutstein at Harvard Medical School in the USA in the 1970 s  and is based on the idea that deaths from certain causes, and at certain ages, should not occur in the presence of timely and effective health care. Rutstein’s group introduced the notion of ‘unnecessary untimely deaths’ that should be considered as ‘sentinel health events’ and so may provide a marker of the quality of care. This approach has been applied to the study of international and regional variations in mortality , and to the study of racial and socioeconomic variations in mortality .
For example, we have recently published a study on educational variations in mortality from conditions amenable to medical intervention in 16 European populations. This study showed that inequalities in mortality from these conditions are often substantial, and contribute between 11 and 24% to inequalities in partial life expectancy between the ages of 30 and 64 . This study could, however, not provide certainty about whether these inequalities really reflect inequalities in access or quality of health care services. Given the fact that people from lower socioeconomic groups are exposed to many forms of material and immaterial disadvantage, there is a distinct possibility that inequalities in mortality from conditions amenable to medical intervention are caused by inequalities in the background risk of disease or prognostic factors, instead of being caused by inequalities in health care factors.
We therefore decided to determine whether inequalities in mortality from conditions amenable to medical intervention vary between countries in patterns which differ from those observed for other (non-amenable) causes of death. More specifically, we hypothesized that, as compared to non-amenable causes, inequalities in mortality from amenable causes are more strongly associated with inequalities in health care use, and are less strongly associated with inequalities in common risk factors for disease such as smoking.
Descriptive information on databases included in the analyses
Type of data
No of person yrs at risk
No. of respondents
Spain (Madrid region)
Spain (Basque country)
Central and Eastern Europe
The list of causes of death amenable to medical intervention was based on the original list developed by Rutstein  and as also used in Stirbu et al , but we added a few additional causes of death based on recent updates [11–14]: colorectal cancer (advances in early detection using colonoscopy and in treatment using chemotherapy), other heart disease (advances in drug treatment) and ischemic heart disease (introduction of beta-blockers and coronary care units). We apply a strict boundary of the health care system by including only actions delivered by those working within the health care sector (including public health agencies, but excluding institutions engaged in intersectoral action). The causes of death selected for the analysis reported here are shown in Additional file 1: Table S 1, with their code numbers according to the Ninth and Tenth revisions of the International Classification of Diseases. As life expectancy in Europe has been rising we applied an age-limit of 75 years (instead of 65 years as in some previous studies).
Survey data on health care use and behavioural risk factors
Data on health care use and risk factors for disease were obtained from national health or multipurpose surveys (Table 1). Data were available for 12 of the 14 countries for which mortality data were available. Unfortunately, we did not have access to survey data for Switzerland and Poland. All data were nationally representative. Self-reported health care use comprised visits to general practitioners (GP), visits to specialists and/or visits to any doctor in a specified period preceding the interview, and hospital admission in the past year. The use of medication was measured as the use of any types of medicines and the use of prescribed medicine in a specified recall period. The use of preventive health care was captured in questions relating to the attendance of breast and cervical cancer screening, and cholesterol and blood pressure measurements. The specified recall period varied between the countries.
Behavioural risk factors for disease for which data were available in a form that enabled them to be compared across countries were current tobacco smoking and overweight (measured on the basis of self-reported height and weight, with BMI > 25 as a cut-off point). To supplement this information we also studied inequalities in smoking-related causes of death (cancer of buccal cavity, pharynx and oesophagus, cancer of larynx, cancer of trachea, bronchus, lung and COPD) and alcohol-related causes of death (alcoholic cirrhosis of the liver and inflammation of the pancreas, accidental poisoning by alcohol, alcoholic psychosis, dependence, abuse) which we used as proxies for inequalities in exposure to these risk factors (selected ICD codes are given in Additional file 1: Table S 2.
In both the mortality and the survey data we used educational level as a measure of socioeconomic position. In order to increase comparability between countries and data sources, educational levels were categorized as ‘lower education’ (no or primary education and lower secondary education) and ‘higher education’ (upper secondary education, and post-secondary/tertiary education).
Analysis of mortality and survey data
The analysis of data from longitudinal studies with about 10 years of follow-up was limited to people aged 30–74 years at start of follow-up. To create populations with an approximately equal average age at death, the analysis was performed on slightly younger age-groups for studies with a longitudinal design as compared to the cross-sectional studies (35–79 years). For longitudinal studies with a shorter follow-up period the following age limits were used: 35–79 years for Madrid, and 30–79 years for Belgium and the Basque country (Spain).
We estimated the mortality level of each educational group by calculating age-standardized mortality rates (ASMR) using the European population as a standard (WHO). To assess the association between educational level and mortality rates we also calculated relative risks with 95% confidence intervals using Poisson regression adjusting for age and sex. Because previous analyses had shown that international patterns of educational inequalities in mortality are largely similar for men and women , and in order to avoid problems with small numbers of deaths, no sex-specific analyses were performed in this study. Inequalities in health care use and behavioural risk factors were estimated using a multivariate logistic regression model. All odds ratios were adjusted for age and sex. The use of health care was also adjusted for self-rated health. The reference category for all relative risks and odds ratios was the highest educational group.
In order to determine whether inequalities in mortality from conditions amenable to medical intervention are patterned differently from inequalities in mortality from causes of death not amenable by medical interventions, we used scatter plots and calculated Pearson correlations. We also used Pearson correlations to observe whether inequalities in mortality from conditions amenable to medical intervention are associated with inequalities in health care use or behavioural risk factors. A strong correlation was defined as a Pearson correlation below −0.6 or above 0.6. The correlations were only studied if data were available for at least 50% of the countries, therefore we were able to study the following variables: visit to any doctor, use of any medication, hospital admission, blood pressure screening in the last 5 years, cholesterol screening in the last 5 years, overweight, smoking, smoking-related causes of death and alcohol-related causes of death.
All data used in the analyses have been routinely collected by statistical agencies, and were anonymized before they were supplied to us. Under these conditions, national regulations do not require ethical review of study proposals.
Inequalities in mortality
Table 1 shows the specifics of the mortality databases and the survey data used in this report. For 9 countries longitudinal mortality data (in the case of Italy and Spain limited to specific regions), and for 5 others cross-sectional mortality data were available. For 12 countries survey data were available on use of health care and behavioural risk factors.
Numbers of deaths, age standardized mortality rates, and relative risks comparing lower to higher educational level for total, amenable and non-amenable mortality, by country
Non amenable causes
Amenable causes of death
No. of deaths
Nr of deaths
Nr of deaths
Spain (Madrid region)
Spain (Basque country)
Central and Eastern Europe
Correlation between inequalities in amenable mortality and inequalities in mortality from all causes and from non-amenable causes
Cause of death
Correlation between inequalities in amenable mortality and inequalities in all-cause mortality (Pearson r)
Correlation between inequalities in amenable mortality and inequalities in mortality from non-amenable causes (Pearson r)
All infectious diseases
Other infectious disease
All amenable cancers
Hodgkin’s disease and leukaemia
All amenable cardiorespiratory conditions
Ischaemic heart disease
Chronic rheumatic heart disease
Other heart disease
Gastro intestinal conditions
All amenable gastrointestinal conditions
Appendicitis, hernia, peptic ulcer
Cholecystitis and -lithiasis
Inequalities in determinants of mortality
Educational inequalities in use of health care comparing low educational to high educational level
Visit any doctor*
Use of any medication*
Use of prescribed medicine*
Cholesterol screening in last 5 years
Blood pressure screening in the last 5 years
Cervical cancer screening
Central and Eastern Europe
Inequalities in smoking and overweight in European countries between low and high educational groups
Central and Eastern Europe
Association between inequalities in mortality and inequalities in determinants
Correlation between inequalities in amenable mortality, inequalities in use of health care † and inequalities in behavioural risk factors
Cause of death
Use of health care
Behavioural risk factors
Visit any doctor
Use of medication
Smoking related deaths
Alcohol related deaths
Number of observations
Non amenable causes of death
All amenable infectious diseases
All amenable cancers
All amenable cardiorespiratory conditions
All amenable gastrointestinal conditions
As seen in Table 6, consistently positive associations are found between inequalities in amenable mortality and inequalities in smoking or smoking-related mortality. In this case a positive correlation implies that larger inequalities in smoking (as indicated by an odds ratio farther above 1) go together with larger inequalities in amenable mortality. As expected, a positive correlation is also observed between inequalities in smoking and smoking-related mortality and inequalities in mortality from non-amenable causes. As compared with non-amenable causes, inequalities in amenable causes are not less strongly associated with inequalities in smoking or smoking-related deaths. Positive associations are also seen between inequalities in amenable mortality and inequalities in alcohol-related deaths, but not with inequalities in overweight.
Summary of findings
In most countries and for most amenable causes of death substantial inequalities in mortality were observed, but inequalities in mortality from amenable causes did not vary between countries in patterns that could be distinguished from those seen for inequalities in non-amenable mortality. More specifically, our hypothesis that, as compared to non-amenable causes, inequalities in mortality from amenable causes are more strongly associated with inequalities in health care use and less strongly with inequalities in common risk factors for disease such as smoking, was not supported by the data. Inequalities in mortality from amenable causes are larger in countries with larger inequalities in visits to any doctor, but so are inequalities from non-amenable causes. And just like inequalities in mortality from non-amenable causes, inequalities in mortality from amenable conditions also tended to be larger in countries where inequalities in smoking, smoking-related deaths and alcohol-related deaths were larger.
This study has several limitations. As shown by the variation between studies in selection of causes of death deemed to be amenable to health care intervention  this selection is to some extent arbitrary. Our selection is somewhat wider than that used in previous studies, including the study by Stirbu  to which this is a follow-up. Because our results are rather consistent across amenable causes of death, we do not think that other selections would have led to substantially different results.
Specific attention should be paid to mortality from HIV/AIDS, which was largely missing from our data. It is only after about 1995 that HIV/AIDS was distinguished as a cause of death. Due to this exclusion, inequalities in mortality from infectious diseases may have been underestimated. This underestimation may be particularly large for southern European countries, which were severely affected by the AIDS/HIV epidemic in the 1990s. It is therefore of special interest to have the results for the Basque country, the only Southern population for which HIV/AIDS deaths were included. Compared to Barcelona, Madrid and Turin, larger relative inequalities in mortality from other infectious diseases were found in the Basque country (Additional file 1: Table S 3).
Our study had to rely on routinely collected mortality data, which are not necessarily fully comparable between countries. Differences between countries in certification and coding of causes of death are unlikely to have affected our results, because our focus is on comparing lower and higher educated groups within the same country. Our results would only be biased if there is an association between country-specific certification or coding practices and educational level, which is not likely. Most of the mortality data used in this study were census-linked, but data from some Central and Eastern European countries and the Baltic region were based on a cross-sectional unlinked design. This limitation has been discussed in the paper of Stirbu et al  and is not likely to substantially affect our results.
For most of the determinants our study had to rely on national health or multipurpose surveys, and self-reported data on health care use and behavioural risk factors may be unreliable. The different national surveys varied in phrasing of the questions, answer categories, recall periods and response rates. However, the influence of these differences on the outcome of this study can be expected to be limited. Inequalities in reporting between socioeconomic groups will only have affected our results if these inequalities also differed between countries, which is less likely. Also, a comparison between inequalities in self-reported smoking and mortality from smoking-related causes (Table 5) shows a reasonable degree of correspondence. The limited number of countries available for our correlation analysis also limits the scope of our analysis.
Unfortunately, the number of determinants of mortality that could be included in our analysis was limited. More extensive or more detailed data on inequalities in health care use might have led to different findings, because previous studies have shown that there are socioeconomic inequalities in use of specific medical procedures in many countries [16–19]. However, comparable information on inequalities in application of specific interventions is not available.
In accordance with previous studies [9, 20] we found that a lower educational level is associated with a substantially higher mortality from causes thought to be amenable to medical intervention. These inequalities are particularly large in Central and Eastern Europe and the Baltic region, and have led to speculations about the role of inequalities in access or quality of health care in explaining the large inequalities in all-cause mortality in these countries [21–23]. The current study, however, has not found clear evidence for a role of health care, and suggests that larger inequalities in amenable mortality may instead be due to the same risk factors as those involved in other causes of death.
Many authors have commented on the possibility that observed variations in amenable mortality (between countries, regions, social groups) may be due to variations in background risk, and not in access or quality of health care. It is easy to see that this might be the case, because levels of cause-specific mortality are not only influenced by survival rates but also by the incidence rates of the underlying diseases. Incidence rates of conditions amenable to medical intervention may differ between socioeconomic groups, because they differ in exposure to the determinants of incidence (e.g. material living conditions, behavioural risk factors, psychosocial conditions). Our finding that lower educational groups have a higher prevalence of negative health behaviour, such as smoking, obesity and excessive alcohol use, is in line with what others have found [24–26]. It is interesting to see that in our study the largest inequalities were found in mortality from infectious diseases, e.g. tuberculosis. Although we cannot exclude the possibility that survival from TB is lower among the lower educated, due to inequalities in access or quality of health care, it is well-known that incidence is also higher . In the Baltic countries the high inequalities in mortality from TB might also be explained by alcohol use, which has been shown in an earlier study .
We did find inequalities in the use of health care. In a series of studies, Van Doorslaer and colleagues found that inequalities in seeing a specialist are usually “pro-rich”, while seeing a general practitioner is often not related to socio-economic position (after taking health status into account) . Our results (Table 4) are in line with their findings. Previous studies have also reported on a lower use of preventive interventions in lower socioeconomic groups [18, 19], a finding that our study reproduced. A lower use of treatment and control of cardiovascular risk factors has also been found for uninsured adults, who tend to come from the lower socioeconomic groups .
Although we did find an association between inequalities in health care use (i.e., visit to any doctor) and inequalities in amenable mortality, we regard this as potentially spurious because the same association emerged for inequalities in mortality from non-amenable conditions (Table 6). Our study is one among many which has been unable to find consistent and/or exclusive associations between amenable mortality and health care use [31, 32]. Lack of clear evidence of an effect should not be misinterpreted as evidence for lack of an effect, but as the burden of proof lies with those who promote the use of amenable mortality our study urges for caution in the use of these indicators.
Although our findings do not point into the direction of health care, in-depth studies using a more powerful research design may reveal that variations in exposure to shortcomings in health care explain some of the differences in mortality between educational groups. This could be done through a retrospective audit into one specific cause of amenable mortality e.g. TB, colorectal cancer, or cerebrovascular disease. A more ambitious approach would be the performance of a prospective follow up study of one of the amenable conditions, relating socioeconomic variations in mortality outcomes to socioeconomic variations in health care utilization.
We did not find clear evidence that inequalities in mortality from amenable conditions are related to inequalities in access or quality of health care. Further research is needed to find the causes of socioeconomic inequalities in mortality from amenable conditions, and caution should be exercised in interpreting these inequalities as indicating health care deficiencies.
IP carried out the analyses, and write a first draft of the paper. RH advised on the analysis. BA, MB, CB, GC, PD, SE, RK, ML, OL, PM, ER, JR, BHS, and BW collected the data. JM conceived the study, and edited the manuscript. All authors commented on the manuscript, and approved the final version.
This study was financially supported by a grant from the World Health Organization, European Office, received through the European Observatory of Health Systems and Policies. The data used in the analysis were collected in the framework of the Eurothine study, which was financially supported by the European Commission (grant number 2003125).
- Marmot M: Social determinants of health inequalities. Lancet. 2005, 365 (9464): 1099-1104.View ArticlePubMedGoogle Scholar
- Mackenbach J: Health inequalities: Europe in Profile. 2006, Department of Health, LondonGoogle Scholar
- Mackenbach JP, Bos V, Andersen O, Cardano M, Costa G, Harding S, et al: Widening socioeconomic inequalities in mortality in six Western European countries. Int J Epidemiol. 2003, 32 (5): 830-837. 10.1093/ije/dyg209.View ArticlePubMedGoogle Scholar
- Lahelma E, Lundberg O: Health inequalities in European welfare states. Eur J Public Health. 2009, 19 (5): 445-446. 10.1093/eurpub/ckp120.View ArticlePubMedGoogle Scholar
- Lemstra M, Mackenbach J, Neudorf C, Nannapaneni U: High health care utilization and costs associated with lower socio-economic status: results from a linked dataset. Can J Public Health. 2009, 100 (3): 180-183.PubMedGoogle Scholar
- Tuppin P, Drouin J, Mazza M, Weill A, Ricordeau P, Allemand H: Hospitalization admission rates for low-income subjects with full health insurance coverage in France. Eur J Public Health. 2011, 21 (5): 560-566. 10.1093/eurpub/ckq108.View ArticlePubMedGoogle Scholar
- Rutstein D, Berenberg W, Chalmers T, Child C, Fishman A, Perrin E: Measuring the quality of medical care. N Engl J Med. 1976, 294: 582-588. 10.1056/NEJM197603112941104.View ArticlePubMedGoogle Scholar
- Charlton J, Hartley R, Silver R, Holland W: Geographical variation in mortality from conditions amenable to medical intervention in England and Wales. Lancet. 1983, i: 691-696.View ArticleGoogle Scholar
- Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, et al: Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008, 358 (23): 2468-2481. 10.1056/NEJMsa0707519.View ArticlePubMedGoogle Scholar
- Stirbu I, Kunst AE, Bopp M, Leinsalu M, Regidor E, Esnaola S, et al: Educational inequalities in avoidable mortality in Europe. J Epidemiol Community Health. 2010, 64 (10): 913-920. 10.1136/jech.2008.081737.View ArticlePubMedGoogle Scholar
- Tobias M, Jackson G: Avoidable mortality in New Zealand, 1981–97. Aust N Z J Public Health. 2001, 25: 12-20. 10.1111/j.1467-842X.2001.tb00543.x.View ArticlePubMedGoogle Scholar
- Nolte E, McKee M: Does healthcare save lives? Avoidable mortality revisited. 2004, The Nuffield Trust, LondonGoogle Scholar
- Nolte E, McKee M: Measuring the health of nations: analysis of mortality amenable to health care. BMJ. 2003, 327 (7424): 1129-10.1136/bmj.327.7424.1129.View ArticlePubMedPubMed CentralGoogle Scholar
- Plug I, Hoffmann R, Khoshaba B, McKee M, Rey G, Jougla E, Westerling R, Parna K, Lang K, Alfonso J, Hellmeier W, Mackenbach JP: Amenable mortality revisited, the AMIEHS study. 2011, ErasmusMC, department of Public Health, RotterdamGoogle Scholar
- Mackenbach J, Bouvier-Colle M, Jougla E: “Avoidable” mortality and health services: a review of aggregate data studies. J Epidemiol Commun Health. 1990, 44: 106-111. 10.1136/jech.44.2.106.View ArticleGoogle Scholar
- Baker L, Quinlan PR, Patten N, Ashfield A, Birse-Stewart-Bell LJ, McCowan C, et al: p53 mutation, deprivation and poor prognosis in primary breast cancer. Br J Cancer. 2010, 102 (4): 719-726. 10.1038/sj.bjc.6605540.View ArticlePubMedPubMed CentralGoogle Scholar
- Ferguson HJ, Nightingale P, Pathak R, Jayatunga AP: The influence of socio-economic deprivation on rates of major lower limb amputation secondary to peripheral arterial disease. Eur J Vasc Endovasc Surg. 2010, 40 (1): 76-80. 10.1016/j.ejvs.2010.03.008.View ArticlePubMedGoogle Scholar
- Fransen MP, Wildschut HI, Mackenbach JP, Steegers EA, Galjaard RJ, Essink-Bot ML: Ethnic and socio-economic differences in uptake of prenatal diagnostic tests for Down’s syndrome. Eur J Obstet Gynecol Reprod Biol. 2010, 151 (2): 158-162. 10.1016/j.ejogrb.2010.04.020.View ArticlePubMedGoogle Scholar
- von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al: Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011, 40 (3): 712-718. 10.1093/ije/dyr008.View ArticlePubMedGoogle Scholar
- Nolasco A, Melchor I, Pina JA, Pereyra-Zamora P, Moncho J, Tamayo N, et al: Preventable avoidable mortality: evolution of socioeconomic inequalities in urban areas in Spain, 1996–2003. Health Place. 2009, 15 (3): 702-711.View ArticlePubMedGoogle Scholar
- Matuz M, Benko R, Doro P, Hajdu E, Nagy G, Nagy E, et al: Regional variations in community consumption of antibiotics in Hungary, 1996–2003. Br J Clin Pharmacol. 2006, 61 (1): 96-100. 10.1111/j.1365-2125.2005.02525.x.View ArticlePubMedPubMed CentralGoogle Scholar
- Balabanova D, McKee M: Access to health care in a system transition: the case of Bulgaria. Int J Health Plann Manage. 2002, 17 (4): 377-395. 10.1002/hpm.687.View ArticlePubMedGoogle Scholar
- Habicht J, Kiivet RA, Habicht T, Kunst AE: Social inequalities in the use of health care services after 8 years of health care reforms - a comparative study of the Baltic countries. Int J Public Health. 2009, 54 (4): 250-259. 10.1007/s00038-009-8012-x.View ArticlePubMedGoogle Scholar
- Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J: Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA. 1998, 279 (21): 1703-1708. 10.1001/jama.279.21.1703.View ArticlePubMedGoogle Scholar
- Pokhrel A, Martikainen P, Pukkala E, Rautalahti M, Seppa K, Hakulinen T: Education, survival and avoidable deaths in cancer patients in Finland. Br J Cancer. 2010, 103 (7): 1109-1114. 10.1038/sj.bjc.6605861.View ArticlePubMedPubMed CentralGoogle Scholar
- Van der Heyden JH, Schaap MM, Kunst AE, Esnaola S, Borrell C, Cox B, et al: Socioeconomic inequalities in lung cancer mortality in 16 European populations. Lung Cancer. 2009, 63 (3): 322-330. 10.1016/j.lungcan.2008.06.006.View ArticlePubMedGoogle Scholar
- Cantwell MF, McKenna MT, McCray E, Onorato IM: Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med. 1998, 157 (4 Pt 1): 1016-1020.View ArticlePubMedGoogle Scholar
- Lonnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C: Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Publ Health. 2008, 8: 289-10.1186/1471-2458-8-289.View ArticleGoogle Scholar
- van Doorslaer E, Masseria C, Koolman X: Inequalities in access to medical care by income in developed countries. Cmaj. 2006, 174 (2): 177-183. 10.1503/cmaj.050584.View ArticlePubMedPubMed CentralGoogle Scholar
- Brooks EL, Preis SR, Hwang SJ, Murabito JM, Benjamin EJ, Kelly-Hayes M, et al: Health insurance and cardiovascular disease risk factors. Am J Med. 2010, 123 (8): 741-747. 10.1016/j.amjmed.2010.02.013.View ArticlePubMedPubMed CentralGoogle Scholar
- Poikolainen K, Eskola J: Health services resources and their relation to mortality from causes amenable to health care intervention: a cross-national study. Int J Epidemiol. 1988, 17 (1): 86-89. 10.1093/ije/17.1.86.View ArticlePubMedGoogle Scholar
- Kunst AE, Looman CW, Mackenbach JP: Medical care and regional mortality differences within the countries of the European community. Eur J Popul. 1988, 4 (3): 223-245. 10.1007/BF01796895.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/12/346/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.